» Articles » PMID: 25534683

Exploring Advantages/disadvantages and Improvements in Overcoming Gene Delivery Barriers of Amino Acid Modified Trimethylated Chitosan

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 2014 Dec 24
PMID 25534683
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Present study aimed at exploring advantages/disadvantages of amino acid modified trimethylated chitosan in conquering multiple gene delivery obstacles and thus providing comprehensive understandings for improved transfection efficiency.

Methods: Arginine, cysteine, and histidine modified trimethyl chitosan were synthesized and employed to self-assemble with plasmid DNA (pDNA) to form nanocomplexes, namely TRNC, TCNC, and THNC, respectively. They were assessed by structural stability, cellular uptake, endosomal escape, release behavior, nuclear localization, and in vitro and in vivo transfection efficiencies. Besides, sodium tripolyphosphate (TPP) was added into TRNC to compromise certain disadvantageous attributes for pDNA delivery.

Results: Optimal endosomal escape ability failed to bring in satisfactory transfection efficiency of THNC due to drawbacks in structural stability, cellular uptake, pDNA liberation, and nuclear distribution. TCNC evoked the most potent gene expression owing to multiple advantages including sufficient stability, preferable uptake, efficient pDNA release, and high nucleic accumulation. Undesirable stability and insufficient pDNA release adversely affected TRNC-mediated gene transfer. However, incorporation of TPP could improve such disadvantages and consequently resulted in enhanced transfection efficiencies.

Conclusions: Coordination of multiple contributing effects to conquer all delivery obstacles was necessitated for improved transfection efficiency, which would provide insights into rational design of gene delivery vehicles.

Citing Articles

The Multifaceted Histidine-Based Carriers for Nucleic Acid Delivery: Advances and Challenges.

He J, Xu S, Mixson A Pharmaceutics. 2020; 12(8).

PMID: 32823960 PMC: 7465012. DOI: 10.3390/pharmaceutics12080774.


Biodegradable Polymers for Gene Delivery.

Thomas T, Tajmir-Riahi H, Pillai C Molecules. 2019; 24(20).

PMID: 31627389 PMC: 6832905. DOI: 10.3390/molecules24203744.


Starch-Chitosan Polyplexes: A Versatile Carrier System for Anti-Infectives and Gene Delivery.

Yasar H, Ho D, De Rossi C, Herrmann J, Gordon S, Loretz B Polymers (Basel). 2019; 10(3).

PMID: 30966288 PMC: 6415184. DOI: 10.3390/polym10030252.


Delivery of expression constructs of secreted frizzled-related protein 4 and its domains by chitosan-dextran sulfate nanoparticles enhances their expression and anti-cancer effects.

Perumal V, Arfuso F, Chen Y, Fox S, Dharmarajan A Mol Cell Biochem. 2017; 443(1-2):205-213.

PMID: 29185158 DOI: 10.1007/s11010-017-3225-4.


Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy.

Babu A, Ramesh R Mar Drugs. 2017; 15(4).

PMID: 28346381 PMC: 5408242. DOI: 10.3390/md15040096.


References
1.
Ding J, He R, Zhou G, Tang C, Yin C . Multilayered mucoadhesive hydrogel films based on thiolated hyaluronic acid and polyvinylalcohol for insulin delivery. Acta Biomater. 2012; 8(10):3643-51. DOI: 10.1016/j.actbio.2012.06.027. View

2.
Kim T, Ou M, Lee M, Kim S . Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems. Biomaterials. 2008; 30(4):658-64. PMC: 2642962. DOI: 10.1016/j.biomaterials.2008.10.009. View

3.
Schmitz T, Bravo-Osuna I, Vauthier C, Ponchel G, Loretz B, Bernkop-Schnurch A . Development and in vitro evaluation of a thiomer-based nanoparticulate gene delivery system. Biomaterials. 2006; 28(3):524-31. DOI: 10.1016/j.biomaterials.2006.08.017. View

4.
Zhao X, Yin L, Ding J, Tang C, Gu S, Yin C . Thiolated trimethyl chitosan nanocomplexes as gene carriers with high in vitro and in vivo transfection efficiency. J Control Release. 2010; 144(1):46-54. DOI: 10.1016/j.jconrel.2010.01.022. View

5.
Zheng H, Tang C, Yin C . The effect of crosslinking agents on the transfection efficiency, cellular and intracellular processing of DNA/polymer nanocomplexes. Biomaterials. 2013; 34(13):3479-88. DOI: 10.1016/j.biomaterials.2013.01.072. View